Sialanar Drug Utilisation Study

Welcome to the website for the Sialanar Drug Utilisation Study. Proveca are conducting an observational study to assess the value of the materials available to prescribers and carers to promote the safe and effective use of Sialanar. If you are interested in finding out more about this study, please click the button below and complete the registration form. You will be contacted by a member of the Proveca Clinical Team to discuss the study in more detail to help you decide if you would like to participate.

Proveca Ltd is a specialist UK pharmaceutical company developing and licensing off-patent medicines to improve the lives of children in Europe, many of whom have chronic conditions requiring long term drug treatment.